GWM
ARMP icon

GSB Wealth Management’s Armata Pharmaceuticals ARMP Stock Holding History

GSB Wealth Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$307K Hold
30,000
– – 0.07% 182
2025
Q4 		$188K Hold
30,000
– – 0.04% 215
2025
Q3 		$89.4K Hold
30,000
– – 0.02% 223
2025
Q2 		$57K Buy
+30,000
New +$48.6K 0.01% 227

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GSB Wealth Management's ARMP Position: Q1 2026 in Review

GSB Wealth Management held its Armata Pharmaceuticals (ARMP) position steady in Q1 2026 at 30,000 shares worth $307K. The position accounts for 0.07% of the portfolio, ranked #182.

GSB Wealth Management first reported a position in ARMP in Q2 2025 and has held it in 4 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • GSB Wealth Management held 30,000 shares of Armata Pharmaceuticals worth $307K as of Q1 2026.
  • GSB Wealth Management left its Armata Pharmaceuticals share count unchanged in Q1 2026.
  • Armata Pharmaceuticals made up 0.07% of GSB Wealth Management's portfolio in Q1 2026, its #182 holding.
  • GSB Wealth Management first reported a position in Armata Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on GSB Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.